country

Change Language

EN - English
FR - Français
DE - Deutsch
ES - Español
JA - 日本語
KO - 한국어

Country or Region:

United States

Product Name	Size / Unit Price	Qty

Total: USD 0.00 Checkout

7 Results for "

PALM cells

" in MedChemExpress (MCE) Product Catalog:

Products (7)

Sort by :

Categories

By Targets

Products

S-palm P0(180–199) TFA

1 Cited Publications

Cat. No.: HY-P10441A

Target:

Interleukin Related IFNAR

Research Areas:

Inflammation/Immunology

S-palm P0(180-199) TFA is an S-palmitoylated peptide derived from P0 protein. S-palm P0(180-199) TFA induces IL-17+ cells, macrophage infiltration, and anti-P0 antibodies. S-palm P0(180-199) TFA induces chronic inflammatory demyelinating polyneuropathy in rats via active immunization, manifesting as a relapsing-remitting disease driven by persistent T cells, macrophages, Th17 cells and related cytokines, and P0-specific IgG . S-palm P0(180-199) TFA can be used in research related to chronic inflammatory demyelinating polyneuropathy .

Compare

Please select quantity

August 31

Get Quote

View All Sizes

β-Tocotrienol

Cat. No.: HY-108693

CAS No.: 490-23-3

Purity: 98.89%

Target:

Leukotriene Receptor Apoptosis

Research Areas:

Inflammation/Immunology Cancer

β-Tocotrienol is an isomer of vitamin E. β-Tocotrienol is a less potent antioxidant than α-tocotrienol. β-Tocotrienol can be found in the tocotrienol-rich fraction (TRF) of palm oil, which possesses anti-carcinogenic effects in vitro on human colon carcinoma and prostate cancer cells. β-Tocotrienol inhibits the growth of A549 (GI₅₀ = 1.38 μM) and U87MG (GI₅₀ = 2.53 μM) cells. β-Tocotrienol also induces apoptosis in cancer cells. β-Tocotrienol can inhibit PD-L1 expression and mitigates PD-L1-mediated immune suppression in vitro and in vivo .

Compare

Please select quantity

August 31

Get Quote

View All Sizes

di-Pal-MTO

Cat. No.: HY-148702

CAS No.: 1349197-90-5

Purity: 98.37%

di-Pal-MTO is a palm oil-based lipid produced by combining the anticancer agent mitoxantrone (MTO) with palmitoleic acid. When nanoparticles of mono-Pal-MTO and di-Pal-MTO are combined in a molar ratio of 1:1, they show effective siRNA cell delivery and enhance anticancer activity .

Compare